This company listing is no longer active
Think Research Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Think Research's earnings have been declining at an average annual rate of -12.5%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 39.7% per year.
Belangrijke informatie
-12.5%
Groei van de winst
11.9%
Groei van de winst per aandeel
Healthcare Services Groei van de industrie | -3.9% |
Inkomstengroei | 39.7% |
Rendement op eigen vermogen | -54.8% |
Nettomarge | -18.0% |
Laatste winstupdate | 30 Sep 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Is Think Research (CVE:THNK) Using Debt In A Risky Way?
Feb 10Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding
Dec 18Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge
Sep 06Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate
Feb 28Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report
Dec 01Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long
Mar 30Opbrengsten en kosten
Hoe Think Research geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 23 | 85 | -15 | 34 | 8 |
30 Jun 23 | 84 | -18 | 34 | 7 |
31 Mar 23 | 80 | -23 | 36 | 7 |
31 Dec 22 | 79 | -26 | 36 | 7 |
30 Sep 22 | 76 | -28 | 38 | 9 |
30 Jun 22 | 68 | -32 | 38 | 9 |
31 Mar 22 | 60 | -30 | 35 | 8 |
31 Dec 21 | 48 | -29 | 33 | 8 |
30 Sep 21 | 32 | -35 | 27 | 7 |
30 Jun 21 | 26 | -24 | 20 | 6 |
31 Mar 21 | 20 | -22 | 16 | 6 |
31 Dec 20 | 17 | -18 | 13 | 6 |
30 Sep 20 | 19 | -10 | 17 | 5 |
30 Jun 20 | 20 | -11 | 17 | 6 |
30 Sep 19 | 17 | -13 | 15 | 7 |
30 Sep 18 | 15 | -12 | 16 | 8 |
Kwaliteitswinsten: THNK is currently unprofitable.
Groeiende winstmarge: THNK is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: THNK is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.
Versnelling van de groei: Unable to compare THNK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: THNK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Rendement op eigen vermogen
Hoge ROE: THNK has a negative Return on Equity (-54.78%), as it is currently unprofitable.